Clinical Trials Browser

Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Kidney Neoplasms, Lung Neoplasms, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms

NCT06130332 2023-11-14

Neoadjuvant Tirellizumab Combined With Chemotherapy for Early Oral Squamous Cell Carcinoma(HNC-SYSU-004)

Phase 2 Recruiting

40 enrolled

Head & Neck

Mouth Neoplasms

NCT04813705 2023-02-21

18F-FDG PET/CT Guided Reduced-dose Radiotherapy for Nasopharyngeal Carcinoma

Phase 2 Recruiting

93 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT05145660 2022-09-27

Optimization of Cervical Nodal CTV for Early and Medium Stage NPC

Phase 3 Recruiting

414 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT05340491 2022-08-31

Chemoradiotherapy Plus Anti-PD1 in Recurrent NPC: A Multicenter, Open-label, Randomised, Controlled, Phase III Trial

Phase 3 Recruiting

212 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT05350891 2022-05-10

Transnasal Endoscopic Surgery Combined With Adjuvant Immunotherapy for Recurrent NPC

Phase 2 Recruiting

77 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT04220749 2020-09-04

Radiotherapy vs. Trans-Oral Surgery for HPV-Negative Oropharyngeal Squamous Cell Carcinoma

Phase 2 Recruiting

68 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Clinical Trials

Invert-Prospective Phase II Randomized Trial of Involved Nodal Versus Elective Neck RadioTherapy

Clinical and Molecular Features of Oral Premalignancy and Oral Cancer

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

(NeoScorch HN)

Iparomlimab and Tuvonralimab Plus Hypofractionated Radiotherapy and Chemotherapy for HAHNSCC

Decitabine in Combination With Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer

Circulating Tumor Cell Counts in Postoperative ENE-Positive Oral Cavity Cancer Patients After Adjuvant CCRT

Adjuvant vs Surgery Only in Early-stage Recurrent NPC

AK129 Combination Therapy for Advanced Solid Tumors

Study of Pembrolizumab Combined with Chemotherapy in the First Line Therapy for R/M HNSCC in China

Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma

PembroMetaRT

OART

Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors

Neoadjuvant Tirellizumab Combined With Chemotherapy for Early Oral Squamous Cell Carcinoma(HNC-SYSU-004)

18F-FDG PET/CT Guided Reduced-dose Radiotherapy for Nasopharyngeal Carcinoma

Optimization of Cervical Nodal CTV for Early and Medium Stage NPC

Chemoradiotherapy Plus Anti-PD1 in Recurrent NPC: A Multicenter, Open-label, Randomised, Controlled, Phase III Trial

Transnasal Endoscopic Surgery Combined With Adjuvant Immunotherapy for Recurrent NPC

Radiotherapy vs. Trans-Oral Surgery for HPV-Negative Oropharyngeal Squamous Cell Carcinoma